Stock GABA GABATHER AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Gabather AB

Equities

GABA

SE0010869552

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm
Other stock markets
 11:13:21 2024-06-07 EDT 		5-day change 1st Jan Change
1.815 SEK -0.27% Intraday chart for Gabather AB +9.67% +28.72%
05-30 Gabather AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-10 Gabather AB Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct A Clinical Phase II Study with GT-002 CI

Business Summary

Gabather AB is a Sweden-based company engaged pharmaceutical industry. The Company develops drug candidates for the treatment of several diseases originating in the central nervous system (CNS). The Company mainly focuses on anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as conginition-enhancing treatments, including Alzheimer’s disease.

Number of employees: 3

Managers

Managers TitleAgeSince
Michael Robin Witt CEO
 Chief Executive Officer - 14-08-31
Kristofer Svensson DFI
 Director of Finance/CFO - -
Christine Natasha Ryan COO
 Chief Operating Officer - -
Stefan Rehnmark CTO
 Chief Tech/Sci/R&D Officer - -

Members of the board

Members of the board TitleAgeSince
Michael Robin Witt CEO
 Chief Executive Officer - 14-08-31
Bert Roland Kari Junno FOU
 Founder 58 14-11-02
Anders Lönnberg CHM
 Chairman - 20-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,095,681 14,036,677 ( 77.57 %) 0 77.57 %

Company contact information

Gabather AB

Forskargatan 20J Byggn 215 N

151 36, Södertälje

+46 7 36 87 28 39

http://www.gabather.com
address Gabather AB(GABA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
GABATHER AB Stock Gabather AB
+28.72% 3.25M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+18.72% 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+14.19% 108B
BIONTECH SE Stock BioNTech SE
-4.93% 24.21B
ARGENX SE Stock argenx SE
+3.23% 22.78B
GENMAB A/S Stock Genmab A/S
-10.44% 17.96B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.74% 16.43B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.31% 16.37B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.44% 13.58B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+27.89% 11.66B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. GABA Stock
  4. Company Gabather AB